Editorial Comment on Beyond Total PSA : Clinical Significance of S2 , 3PSA % in Reducing Unnecessary Prostate Biopsies

Key Points

• The commentary assesses the clinical importance of S2 and 3PSA percentages in prostate biopsy decision-making.
• Review of current PSA metrics
• Analysis of biopsy outcomes
• Discussion of clinical implications
• S2 and 3PSA metrics may help reduce unnecessary biopsies
• Improved patient selection for biopsies is suggested
• Enhancing diagnostic accuracy in prostate cancer detection is emphasized.

Abstract